Intra-arterial cereport (RMP-7) and carboplatin: A dose escalation study for recurrent malignant gliomas

Neurosurgery

Volumn 44, Issue 2, 1999, Pages 270-279

  Cloughesy, Timothy F ^a   Black, Keith L ^a   Gobin, Y Pierre ^a   Farahani, Keyvan ^a   Nelson, Gillian ^a   Villablanca, Pablo ^a   Kabbinavar, Fairooz ^a   Viñeula, Fernando ^a   Wortel, Cornelius H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALKERMES INC   (United States)

Author keywords

Blood brain barrier; Bradykinin; Brain tumor; Carboplatin; Glioma; Intra arterial; RMP 7

Indexed keywords

ANTINEOPLASTIC AGENT; BRADYKININ; BRADYKININ DERIVATIVE; CARBOPLATIN; LOBRADIMIL; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLIOMA; HEMATOLOGIC DISEASE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRADYKININ; BRAIN NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOMA; HUMANS; INFUSIONS, INTRA-ARTERIAL; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 0032905933     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199902000-00015     Document Type: Article

References (30)

1. Aoki S, Terada H, Kosuda S, Shitara N, Fujii H, Suzuki K, Kutsukake Y, Tanaka J, Sasaki Y, Okubo T, Shirouzu I, Machida T, Sasaki Y: Supraophthalmic chemotherapy with long tapered catheter: Distribution evaluated with intraarterial and intravenous Tc-99m HMPAO. Radiology 188:347-350, 1993.
2. Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK: Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33:270-278, 1996.
3. Black KL, Cloughesy TF, Hoang H, Gobin P, Nelson G, Hoh C, Grous J: RMP-7, a bradykinin analog, increases transport of gallium-68 EDTA into human gliomas. J Neurosurg 86:603-609, 1997.
4. Bobo H, Kapp JP, Vance R: Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: Proposal of a new method of intra-arterial dosage calculation. J Neurooncol 13:291-299, 1992.
5. Clarke LP, Velthuizen RP, Camacho MA, Heine JJ, Vaidyanathan M, Hall LO, Thatcher RW, Silbiger ML: MRI segmentation: Methods and applications. Magn Reson Imaging 13:343-368, 1995.
6. Cloughesy T, Black K: Pharmacological blood-brain barrier modification for selective drug delivery. J Neurooncol 26:125-132, 1995.
7. Cloughesy T, Gobin Y, Black K, Viñuela F, Taft F, Kadkhoda B, Kabbinavar F: Intraarterial carboplatin chemotherapy for brain tumors: A dose escalation study based on cerebral blood flow. J Neurooncol 35:121-132, 1997.
8. Elliott P, Hayward N, Huff M, Nagle T, Black K, Bartus R: Unlocking the blood-brain barrier: A role for RMP-7 in brain tumor therapy. Exp Neurol 141:214-224, 1996.
9. Follezou JY, Fauchon F, Chiras J: Intraarterial infusion of carboplatin in the treatment of malignant gliomas: A Phase II study. Neoplasma 36:349-352, 1989.
10. Ginos JZ, Cooper AJ, Dhawan V, Lai JC, Strother SC, Alcock N, Rottenberg DA: [13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med 28:1844-1852, 1987.
11. Inamura T, Black KL: Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 14:862-870, 1994.
12. Inamura T, Nomura T, Bartus RT, Black KL: Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J Neurosurg 81:752-758, 1994.
13. Kupersmith MJ, Frohman LP, Choi IS, Foo SH, Hiesenger E, Berenstein A, Wise A, Carr RE, Ransohoff J: Visual system toxicity following intra-arterial chemotherapy. Neurology 38:284-289, 1988.
14. Kupersmith MJ, Seiple WH, Holopigian K, Noble K, Hiesiger E, Warren F: Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine. Am J Ophthalmol 113:435-438, 1992.
15. Macdonald D, Cascino T, Schold C, Cairncross J: Response criteria for Phase II studies of supratentorial malignant gliomas. J Clin Oncol 8:1277-1280, 1990.
16. Maiese K, Walker RW, Gargan R, Victor JD: Intra-arterial cisplatin: Associated optic and otic toxicity. Arch Neurol 49:83-86, 1992.
17. Matsukado K, Inamura T, Nakano S, Masashi F, Bartus RT, Black KL: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:125-134, 1996.
18. Nakagawa H, Fujita T, Izumimoto S, Miyawaki Y, Kubo S, Nakajima Y, Tsuruzono K, Kodama K, Higashiyama M, Doi O, Hayakawa T: Cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer: II - Clinical effects. J Neurooncol 16:69-76, 1993.
19. Nakano S, Matsukado K, Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56:4027-4031, 1996.
20. Newton HB, Newton CL: Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma. J Neurooncol 24:285-292, 1995.
21. Newton HB, Page MA, Junck L, Greenberg HS: Intra-arterial cisplatin for the treatment of malignant gliomas. J Neurooncol 7:39-45, 1989.
22. Petersdorf SH, Livingston RB: High dose chemotherapy for the treatment of malignant brain tumors. J Neurooncol 20:155-163, 1994.
23. Riley MG, Kim NN, Watson VE, Gobin YP, LeBel CP, Black KL, Bartus RT: Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: A toxicologic evaluation in swine. J Neurooncol 36:167-178, 1998.
24. Shani J, Bertram J, Russel C, Dahalan R, Chen D, Parti R, Ahmadi J, Kempf R, Kawada T, Muggia F, Wolf W: Noninvasive monitoring of drug biodistribution and metabolism: Studies with intraarterial Pt-195 m-cisplatin in humans. Cancer Res 49:1877-1881, 1989.
25. Shapiro WR, Green SB, Burger PC, Selker RG, Vangilder JC, Robertson JT, Mealey J, Ransohoff J, Mahaley MS: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76:772-781, 1992.
26. Stewart DJ: Pros and cons of intra-arterial chemotherapy. Oncology 3:20-26, 1989.
27. Stewart DJ, Belanger JM, Grahovac Z, Curuvija S, Gionet LR, Aitken SE, Hugenholtz H, Benoit BG, DaSilva VF: Phase I study of intracarotid administration of carboplatin. Neurosurgery 30:512-516, 1992.
28. Vick N, Khandekar J, Bigner D: Chemotherapy of brain tumors: The 'blood brain-barrier' is not a factor. Arch Neurol 34:523-526, 1977.
29. Warnick RE, Prados MD, Mack EE, Chandler KL, Doz F, Rabbitt JE, Malec MK: A Phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol 19:69-74, 1994.
30. Yung WK, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant glioma: A Phase II study. J Clin Oncol 9:860-864, 1991.